Evidence map›Paper›PMID 18606452›Full record

ArticleMolecular immunology2008

The 'zinc knuckle' motif of Early B cell Factor is required for transcriptional activation of B cell-specific genes.

Scott Fields, Kristina Ternyak, Hua Gao, Rachel Ostraat, Janie Akerlund, James Hagman

Open access · greenAbstract read
In one paragraph

Article in Molecular immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Novel de novo variant inCold Spring Harbor molecular case studies · 2017
    Article
  6. Article
  7. De Novo Mutations in EBF3 Cause a Neurodevelopmental Syndrome.American journal of human genetics · 2017
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Compound haploinsufficiencies of Ebf1 and Runx1 genes impede B cell lineage progression.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  18. Review
  19. Opposing effects of SWI/SNF and Mi-2/NuRD chromatin remodeling complexes on epigenetic reprogramming by EBF and Pax5.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  20. Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Scott FieldsIntegrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206, USA.
Kristina Ternyak
Hua Gao
Rachel Ostraat
Janie Akerlund
James Hagman
University of Colorado Denver · USNational Jewish Health · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
THE REGULATION OF V ALPHA 7 EXPRESSING T CELLSP01AI022295 · NIAID · NATIONAL JEWISH HEALTH · PI REFAELI, YOSEF · 1985 to 2011
$11.7M
TRAINING PROGRAM IN IMMUNOLOGYT32AI007405 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Laurel L Lenz, Raul Martin Torres · 1991 to 2026
$10.5M
Function and Regulation of Early B Cell Factor (EBF)R01AI054661 · NIAID · NATIONAL JEWISH HEALTH · PI HAGMAN, JAMES R. · 2004 to 2011
$2.9M
Transcriptional Control and Lineage Commitment by Pax-5R01AI056322 · NIAID · NATIONAL JEWISH HEALTH · PI HAGMAN, JAMES R · 2003 to 2007
$1.5M
NCI NIH HHS P30 CA046934NIAID NIH HHS 5 T32 AI007405NIAID NIH HHS P01 AI022295NIAID NIH HHS P01 AI22295NIAID NIH HHS R01 AI054661NIAID NIH HHS R01 AI056322NIAID NIH HHS R01 AI54661NIAID NIH HHS R01 AI56322NIAID NIH HHS T32 AI007405
6 · The paper itself

Abstract

Early B cell factor (EBF) is a critical regulator of B lymphocyte-specific gene transcription. EBF functions, in part, by binding to regulatory sites of genes required for the pre-B- and mature B cell receptors. These DNA targets include the promoters of the mb-1 and Vpreb1 genes that encode Ig-alpha and one of the components of surrogate light chain, respectively. The biochemical basis of DNA binding and gene activation by EBF is poorly understood. The DNA-binding domain (DBD) of EBF includes a putative zinc-binding motif (HX(3)CX(2)CX(5)C), which we have designated the 'Zn-knuckle'. The Zn-knuckle is required for binding of the mb-1 promoter site in EMSA, but it has not been demonstrated to be important for functional activities of EBF in B cells. Therefore, we expressed EBF with mutations in the Zn-knuckle motif or flanking sequences in plasmacytoma cells in which activation of endogenous mb-1 and Vpreb1 genes is dependent on EBF. EBF with mutations that prevent zinc coordination by the Zn-knuckle did not activate transcription of either target gene. Other mutations affected the sequence preference of DNA binding and differentially inhibited activation of these genes. Our results demonstrate the importance of the Zn-knuckle motif in EBF. These experiments also confirm that EBF can re-activate multiple genes of the early B cell program in plasmacytoma cells, which provide a useful cell-based assay for dissecting mechanisms involving EBF.

Indexed as

Transcriptional ActivationAmino Acid MotifsAmino Acid SequenceAnimalsB-LymphocytesCell LineGenetic VectorsMiceMolecular Sequence DataMutationPAX5 Transcription FactorPlasmacytomaProtein Structure, SecondaryProtein Structure, TertiaryRecombinant ProteinsRetroviridaePAX5 Transcription FactorRecombinant Proteins

Identifiers

PMID18606452
PMCPMC2593158
OpenAlexW1968390885

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.